Sagimet Biosciences(SGMT) - 2025 Q4 - Annual Results

Exhibit 99.2 Targeting Metabolic Dysfunction with Novel Therapies to Treat M ASH, Acne & Cancer March 2026 Forward-Looking Statements and Disclaimer This presentation contains forward-looking statements within the meaning of, and made pursuant to the safe harbor provisions of, The Private Reform Act of 1995. All statements contained in this document, other than statements of historical facts or statements that relate to pre: conditions, including but not limited to, statements regarding possible or assumed ...

Sagimet Biosciences(SGMT) - 2025 Q4 - Annual Results - Reportify